177 related articles for article (PubMed ID: 21822721)
1. Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome.
Bouquier J; Blons H; Narjoz C; Lécuru F; Laurent-Puig P; Bats AS
Fam Cancer; 2011 Dec; 10(4):655-7. PubMed ID: 21822721
[TBL] [Abstract][Full Text] [Related]
2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
3. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
[TBL] [Abstract][Full Text] [Related]
5. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
[TBL] [Abstract][Full Text] [Related]
6. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
7. Simplified identification of Lynch syndrome: a prospective, multicenter study.
Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
[TBL] [Abstract][Full Text] [Related]
8. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
Usha L; Dewdney SB; Buckingham LE
JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
[No Abstract] [Full Text] [Related]
9. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.
Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT
Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970
[TBL] [Abstract][Full Text] [Related]
10. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
12. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome.
van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN;
J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473
[TBL] [Abstract][Full Text] [Related]
13. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability analysis in uterine cavity washings to detect endometrial cancer in Lynch syndrome.
Bats AS; Blons H; Narjoz C; Le Frere-Belda MA; Laurent-Puig P; Lecuru F
Anticancer Res; 2014 Jun; 34(6):3211-5. PubMed ID: 24922696
[TBL] [Abstract][Full Text] [Related]
15. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
[TBL] [Abstract][Full Text] [Related]
17. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?
Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK
Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123
[TBL] [Abstract][Full Text] [Related]
18. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome.
Serrano M; Lage P; Belga S; Filipe B; Francisco I; Rodrigues P; Fonseca R; Chaves P; Claro I; Albuquerque C; Pereira AD
Fam Cancer; 2012 Dec; 11(4):571-8. PubMed ID: 22776989
[TBL] [Abstract][Full Text] [Related]
19. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
Hampel H
J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
[TBL] [Abstract][Full Text] [Related]
20. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
Walsh CS; Blum A; Walts A; Alsabeh R; Tran H; Koeffler HP; Karlan BY
Gynecol Oncol; 2010 Mar; 116(3):516-21. PubMed ID: 20034658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
